Parsey Merdad

CIK 00017921505 companiesNEWTOWN SQUARE, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001792150

Recent Transactions

50 trades

Award
ArriVent BioPharma, Inc.$AVBP
Non-Qualified Stock Option (right to buy)
2026-06-18+13,562→ 13,562 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2026-06-16+39,715→ 39,715 total
Award
ARDELYX, INC.$ARDX
Common Stock
2026-06-16+26,455→ 83,746 total
Award
ArriVent BioPharma, Inc.$AVBP
Non-Qualified Stock Option (right to buy)
2025-06-18+15,502→ 15,502 total
Award
ARDELYX, INC.$ARDX
Common Stock
2025-06-18+15,235→ 57,291 total
Award
ARDELYX, INC.$ARDX
Common Stock
2025-04-28+42,056→ 42,056 total
Award
ArriVent BioPharma, Inc.$AVBP
Stock Option (right to buy)
2025-04-28+28,346→ 28,346 total
Award
ARDELYX, INC.$ARDX
Stock Option (Right to Buy)
2025-04-28+64,457→ 64,457 total
Exercise/Conversion
GILEAD SCIENCES, INC.$GILD
Restricted Stock Unit
2024-12-10−3,820→ 36,753 total
Exercise/Conversion
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-12-10+3,820→ 84,621 total
Tax Payment
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-12-10$92.34/sh−1,771→ 82,850 total
Sale
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-11-27$91.79/sh−57,294→ 187,718 total
Exercise/Conversion
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-11-27$65.38/sh+88,119→ 245,012 total
Sale
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-11-27$91.80/sh−5,200→ 94,399 total
Exercise/Conversion
GILEAD SCIENCES, INC.$GILD
Non-qualified Stock Option (Right to Buy)
2024-11-27−57,294→ 64,376 total
Exercise/Conversion
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-11-27$57.92/sh+57,294→ 156,893 total
Sale
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-11-27$91.80/sh−3,199→ 91,200 total
Exercise/Conversion
GILEAD SCIENCES, INC.$GILD
Non-qualified Stock Option (Right to Buy)
2024-11-27−88,119→ 196 total
Sale
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-11-27$92.00/sh−10,399→ 80,801 total
Sale
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-11-27$92.00/sh−88,119→ 99,599 total
Sale
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-11-06$91.50/sh−20,590→ 104,599 total
Sale
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-11-06$91.50/sh−5,000→ 99,599 total
Exercise/Conversion
GILEAD SCIENCES, INC.$GILD
Non-qualified Stock Option (Right to Buy)
2024-11-06−25,000→ 121,670 total
Exercise/Conversion
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-11-06$57.92/sh+25,000→ 125,189 total
Sale
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-10-01$83.83/sh−2,000→ 100,189 total
Exercise/Conversion
GILEAD SCIENCES, INC.$GILD
Non-qualified Stock Option (Right to Buy)
2024-09-12−25,000→ 146,670 total
Sale
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-09-12$84.50/sh−21,246→ 102,189 total
Exercise/Conversion
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-09-12$57.92/sh+25,000→ 123,435 total
Exercise/Conversion
GILEAD SCIENCES, INC.$GILD
Restricted Stock Unit
2024-09-10−3,821→ 40,573 total
Exercise/Conversion
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-09-10+3,821→ 100,201 total
Tax Payment
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-09-10$81.44/sh−1,766→ 98,435 total
Sale
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-07-01$68.63/sh−2,000→ 96,380 total
Exercise/Conversion
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-06-10+3,820→ 100,124 total
Exercise/Conversion
GILEAD SCIENCES, INC.$GILD
Restricted Stock Unit
2024-06-10−3,820→ 44,394 total
Tax Payment
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-06-10$65.25/sh−1,744→ 98,380 total
Award
Sagimet Biosciences Inc.$SGMT
Stock Option (Right to Buy)
2024-06-05+51,459→ 51,459 total
Sale
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-04-01$72.96/sh−2,000→ 96,304 total
Award
GILEAD SCIENCES, INC.$GILD
Restricted Stock Unit
2024-03-10+17,640→ 48,214 total
Exercise/Conversion
GILEAD SCIENCES, INC.$GILD
Restricted Stock Unit
2024-03-10−3,455→ 37,520 total
Award
GILEAD SCIENCES, INC.$GILD
Non-qualified Stock Option (Right to Buy)
2024-03-10+89,660→ 89,660 total
Exercise/Conversion
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-03-10+6,946→ 103,107 total
Exercise/Conversion
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-03-10+3,455→ 96,161 total
Exercise/Conversion
GILEAD SCIENCES, INC.$GILD
Restricted Stock Unit
2024-03-10−6,946→ 30,574 total
Tax Payment
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-03-10$75.12/sh−4,803→ 98,304 total
Sale
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-02-29$72.74/sh−8,230→ 92,706 total
Sale
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-02-28$73.18/sh−2,000→ 100,936 total
Tax Payment
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-01-31$78.26/sh−23,709→ 102,616 total
Award
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-01-31+20,229→ 69,701 total
Award
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-01-31+56,624→ 126,325 total
Tax Payment
GILEAD SCIENCES, INC.$GILD
Common Stock
2023-12-10$79.02/sh−1,269→ 71,640 total

Companies

Recent Filings

Address

C/O ARRIVENT BIOPHARMA, INC. 18 CAMPUS BOULEVARD SUITE 100

NEWTOWN SQUARE, PA, 19073

View on SEC.gov